Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma

Published:2018-03-05 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Mizuno Yutaka¹,Maemura Kentaro¹,Tanaka Yoshihisa¹,Hirata Azumi¹,Futaki Sugiko¹,Hamamoto Hiroki²,Taniguchi Kohei²,Hayashi Michihiro²,Uchiyama Kazuhisa²,Shibata Masa-Aki¹,Otsuki Yoshinori³,Kondo Yoichi¹

Affiliation:

1. Department of Anatomy and Cell Biology, Osaka Medical College, Takatsuki, Osaka 569-8686, Japan

2. Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Osaka 569-8686, Japan

3. Osaka Medical College, Takatsuki, Osaka 569-8686, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large-scale loss-of-function perturbations reveal a comprehensive epigenetic regulatory network in breast cancer;Cancer Biology & Medicine;2023-12-07

2. Decitabine attenuates the anti-cancer effect of doxorubicin by repressing ECDH1 and inducing SNAI1 and BCL2 in HepG2 hepatocellular carcinoma cells.;Egyptian Journal of Chemistry;2023-04-26

3. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma;Hepatology International;2022-06-01

4. DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis;Genomics;2022-03

5. The Cross-Talk between Epigenetic Gene Regulation and Signaling Pathways Regulates Cancer Pathogenesis;Subcellular Biochemistry;2022